Search research articles
Contact Us
Filters
Showing results (221-230 of 271) with videos related to
Page
of 28
Sort By:
The Journal of Infectious Diseases
|
April 24, 2024
A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention
Sharon A Riddler, Clifton W Kelly, Craig J Hoesley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 18, 2014
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study
Albert Liu, David V Glidden, Peter L Anderson, et al.
BMJ Open
|
July 2, 2021
The Magnetic Couples Study: protocol for a mixed methods prospective cohort study of HIV-serodifferent heterosexual couples' perspectives and use of pre-exposure prophylaxis (PrEP)
James M McMahon, Janie Simmons, Jessica E Haberer, et al.
Journal of the International AIDS Society
|
April 19, 2017
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project
Brenda Hoagland, Ronaldo I Moreira, Raquel B De Boni, et al.
The Lancet. HIV
|
February 13, 2026
Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial
Felix G Mhlanga, Daniel W Szydlo, Ashley J Mayo, et al.
The Lancet. HIV
|
October 31, 2025
Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study
Lee Fairlie, Daniel W Szydlo, Ashley Mayo, et al.
The Lancet. HIV
|
February 23, 2018
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
Beatriz Grinsztejn, Brenda Hoagland, Ronaldo I Moreira, et al.
Journal of the International AIDS Society
|
December 15, 2021
Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first-line therapy in South Africa: a case-control cohort study
Jose R Castillo-Mancilla, Johnathan A Edwards, Jaysingh Brijkumar, et al.
Science Translational Medicine
|
September 14, 2012
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
Peter L Anderson, David V Glidden, Albert Liu, et al.
AIDS (London, England)
|
August 4, 2025
Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV
Sampson Antwi, Hongmei Yang, Anthony Enimil, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 271) with videos related to
Sort By:
Page
of 28
The Journal of Infectious Diseases
|
April 24, 2024
A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention
Sharon A Riddler, Clifton W Kelly, Craig J Hoesley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 18, 2014
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study
Albert Liu, David V Glidden, Peter L Anderson, et al.
BMJ Open
|
July 2, 2021
The Magnetic Couples Study: protocol for a mixed methods prospective cohort study of HIV-serodifferent heterosexual couples' perspectives and use of pre-exposure prophylaxis (PrEP)
James M McMahon, Janie Simmons, Jessica E Haberer, et al.
Journal of the International AIDS Society
|
April 19, 2017
High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project
Brenda Hoagland, Ronaldo I Moreira, Raquel B De Boni, et al.
The Lancet. HIV
|
February 13, 2026
Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial
Felix G Mhlanga, Daniel W Szydlo, Ashley J Mayo, et al.
The Lancet. HIV
|
October 31, 2025
Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study
Lee Fairlie, Daniel W Szydlo, Ashley Mayo, et al.
The Lancet. HIV
|
February 23, 2018
Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study
Beatriz Grinsztejn, Brenda Hoagland, Ronaldo I Moreira, et al.
Journal of the International AIDS Society
|
December 15, 2021
Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first-line therapy in South Africa: a case-control cohort study
Jose R Castillo-Mancilla, Johnathan A Edwards, Jaysingh Brijkumar, et al.
Science Translational Medicine
|
September 14, 2012
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
Peter L Anderson, David V Glidden, Albert Liu, et al.
AIDS (London, England)
|
August 4, 2025
Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV
Sampson Antwi, Hongmei Yang, Anthony Enimil, et al.
Page
of 28